Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5835931 | 0.81 | MGAM (0.46) | TSHRHCAR2GAAHSD17B10MGAM | |
| SCHEMBL11066780 | 0.81 | GAA (0.52) | HCAR2KEAP1NFE2L2GAAHSD17B10 | |
| SCHEMBL2654703 | 0.80 | DGAT1 (0.39) | TSHRHCAR2KEAP1NFE2L2CA12 | |
| SCHEMBL6949768 | 0.79 | — | — | |
| SCHEMBL6945786 | 0.79 | — | — | |
| SCHEMBL195981 | 0.78 | — | — | |
| SCHEMBL11004334 | 0.76 | — | — | |
| SCHEMBL29470046 | 0.76 | — | — | |
| SCHEMBL28355601 | 0.76 | — | — | |
| SCHEMBL212257 | 0.75 | HCAR2 (0.55) | TSHRHCAR2KEAP1NFE2L2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2900645-B1 | HERBICIDAL AND FUNGICIDAL 3-PHENYLISOXAZOLIN DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2019-08-21 | — | — | EP | claimed |
| US-20150245615-A1 | 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION | BAYER CROPSCIENCE AG (DE) | 2015-09-03 | — | — | US | claimed |
| US-7858802-B2 | Method of preparing ionic liquids | BASF SE (DE) | 2010-12-28 | — | — | US | claimed |
| US-20080214536-A1 | Amido-Substituted 6-Phenylphenanthridines | NYCOMED GMBH (DE) | 2008-09-04 | — | — | US | claimed |
| US-20070185149-A1 | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors | ALTANA PHARMA AG (DE) | 2007-08-09 | — | — | US | claimed |
| EP-0188805-B1 | 1,3-DITHIOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-09-06 | — | — | EP | claimed |
| EP-0188805-A1 | 1,3-Dithiole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1986-07-30 | — | — | EP | claimed |
| US-20240240095-A1 | NEW COMPOSITIONS FOR REDUCING CRYSTALLIZATION OF PARAFFIN CRYSTALS IN FUELS | BASF SE (DE) | 2024-07-18 | — | — | US | disclosed |
| WO-2024149635-A1 | BRANCHED AMINES AS ADDITIVES FOR GASOLINE FUELS | BASF SE (DE) | 2024-07-18 | — | — | WO | disclosed |
| US-20240217923-A1 | A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION | BASF (CHINA) COMPANY LIMITED (CN) | 2024-07-04 | — | — | US | disclosed |
| EP-4382588-A1 | ADDITIVES FOR IMPROVING THERMAL STABILITY OF FUELS | BASF SE (DE) | 2024-06-12 | — | — | EP | disclosed |
| CN-118119688-A | Reduction of asphaltenes from marine fuels | 巴斯夫欧洲公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118119689-A | Reduction of asphaltenes from marine fuels | 巴斯夫欧洲公司 | 2024-05-31 | — | — | CN | disclosed |
| US-5025048-A | Oxygen resistant, storage-stable curable polysiloxanes hydrosilated by a polycyclic polyene and a compound containing an amine and a hydroxy, both sterically hindered | HERCULES INCORPORATED (US) | 1991-06-18 | — | — | US | disclosed |
| EP-0413657-A2 | Mono- and diacyl phosphine oxides | CIBA-GEIGY AG (CH) | 1991-02-20 | — | — | EP | disclosed |
| EP-0360747-A2 | Telomeric compound | FMC CORPORATION (UK) LIMITED (GB) | 1990-03-28 | — | — | EP | disclosed |
| US-4211696-A | Disperse monoazo dyestuffs derived from 3,5-dinitro-2-amino thiophene as disazo component and an arylamine coupling component | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-07-08 | — | — | US | disclosed |
| US-4198334-A | HEAT, LIGHT, OXIDATION RESISTANCE, PLASTICS | CIBA-GEIGY CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| EP-0009191-A1 | Water-insoluble disazodyestuffs, their preparation and application | CASSELLA Aktiengesellschaft (DE) | 1980-04-02 | — | — | EP | disclosed |
| US-4013632-A | SYNTHETIC FIBERS | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217923-A1 | A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION | TST, DDT, PAH | TSHR 2772/4885HCAR2 3648/4885KEAP1 1104/4885 |
| US-20070185149-A1 | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors | PDE4A, PDE4B, PDE4C | TSHR 1574/4885HCAR2 1352/4885KEAP1 3918/4885 |
| US-20080214536-A1 | Amido-Substituted 6-Phenylphenanthridines | PDE4A, PDE4B, PDE3A | TSHR 1041/4885HCAR2 2382/4885KEAP1 3749/4885 |
| US-20150245615-A1 | 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION | CYP4X1, CBR3, PAOX | TSHR 1336/4885HCAR2 345/4885KEAP1 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.